Common Contracts
2 similar Letter Agreement contracts by Upstream Bio, Inc.
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Letter AgreementLetter Agreement • September 18th, 2024 • Upstream Bio, Inc. • Pharmaceutical preparations
This letter agreement (the “Letter Agreement”) is entered into by and among (1) Astellas Pharma Inc., a Japanese kabushiki kaisha having a place of business at 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”), (2) Upstream Bio, Inc., a Delaware corporation having a place of business at care of: Maruho Hatsujyo Innovations, 175 Washington Street, Norwell, MA 02061USA (“Buyer”), and (3) Regeneron Pharmaceuticals Inc., a New York corporation with a principal place of business at 777 Old Saw Mill River Road, Tarrytown, New York, 10591 (“Regeneron”). Astellas, Buyer, and Regeneron shall each be referred to herein as a “Party” and shall be collectively referred to herein as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Regeneron Agreement (as defined below).
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Letter AgreementLetter Agreement • July 18th, 2024 • Upstream Bio, Inc. • Pharmaceutical preparations
This letter agreement (the “Letter Agreement”) is entered into by and among (1) Astellas Pharma Inc., a Japanese kabushiki kaisha having a place of business at 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”), (2) Upstream Bio, Inc., a Delaware corporation having a place of business at care of: Maruho Hatsujyo Innovations, 175 Washington Street, Norwell, MA 02061USA (“Buyer”), and (3) Regeneron Pharmaceuticals Inc., a New York corporation with a principal place of business at 777 Old Saw Mill River Road, Tarrytown, New York, 10591 (“Regeneron”). Astellas, Buyer, and Regeneron shall each be referred to herein as a “Party” and shall be collectively referred to herein as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Regeneron Agreement (as defined below).
